You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 776 Long-term efficacy and safety of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy in patients with advanced melanoma: a 4-year analysis of the C-144–01 study

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
776 Long-term efficacy and safety of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy in patients with advanced melanoma: a 4-year analysis of the C-144–01 study

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023566029
Dec 2023122014
Jan 202410709
Feb 2024264041
Mar 2024302046
Apr 2024185030
May 2024184023
Jun 2024126018
Jul 2024224028
Aug 2024204036
Sep 2024216034
Oct 2024180022
Nov 2024236027
Dec 2024256022
Jan 2025210042
Feb 2025120026
Mar 20250028
Apr 20250030
May 20255025
Jun 20250011
Total35070541